The influenza virus is a member of the Orthomyxoviridae family of segmented, single-stranded, negatively charged RNA viruses. Three different influenza virus types—A, B, and C—are included in this group. While type B and C viruses only affect humans, type A viruses affect both domesticated and wild birds, horses, swine, other mammals, and humans.In the United States, seasonal epidemics of disease are brought on by human influenza A and B viruses almost every winter. An influenza pandemic can be brought on by the spread of a brand-new, radically different influenza virus. Infections with influenza type C are thought to only cause a mild respiratory illness and not epidemics. Each virus subtype has undergone mutation, resulting in a variety of strains with various levels of pathogenicity; some are pathogenic to one species but not to others, and some are pathogenic to several.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V101352 | OSC-GCDI(P) | OSC-GCDI(P) is an oral broad-spectrum anti-influenza virus drug that has significant inhibitory effects on both wild-type and oseltamivir-resistant strains (H275Y) in a mouse infection model. | |
|
V109508 | Oseltamivir-fructosyl | 2413185-85-8 | Oseltamivir-fructose has anti-influenza virus activity and also inhibits various bacteria such as Streptococcus and Pseudomonas halophilus. |
|
V117467 | PAC/NP-IN-1 | PAC/NP-IN-1 (compound 30) is a dual-target anti-influenza drug that specifically binds to the nucleoprotein (NP) and C-terminal domain (PAc) of the PA protein. | |
|
V88290 | PAN endonuclease-IN-2 | PAN endonuclease-IN-2 (compound T-31) is a PAN endonuclease inhibitor (IC50: 0.15 μM) and antiviral agent with broad-spectrum anti-influenza activity. | |
|
V110469 | PB2-IN-2 | PB2-IN-2 is an orally effective PB2 inhibitor with an RNP inhibitory activity (IC50) of 0.2 nM, a cell replication inhibitory activity (LRA EC50) of 0.8 nM, and a cytopathic effect inhibitory activity (CPE EC50) of 0.1 nM. | |
|
V95267 | Pimodivir hydrochlorid hemihydrate | 1777721-70-6 | Pimodivir hydrochloride hemihydrate (VX-787) is an oral influenza A virus polymerase inhibitor that works by inhibiting the PB2 subunit. |
|
V116343 | R-1 sodium | R-1 sodium is a nucleic acid aptamer that can bind to non-structural protein 1 (NS1). | |
|
|
V116380 | R-2 sodium | R-2 sodium is a nucleic acid aptamer that can bind to non-structural protein 1 (NS1). | |
|
V99114 | RdRP-IN-8 | RdRP-IN-8 (Compound 45) is an anti-influenza virus compound. | |
|
V103562 | Rifampin/BSA | Rifampicin/BSA is an antigen-adjuvant conjugate of rifampicin conjugated to bovine serum albumin (BSA). | |
|
V119444 | TTHP 512 | TTHP 512 is an inhibitor of influenza A virus (IAV). | |
|
V88288 | UH15-38 | 2540881-21-6 | UH15-38 is a potent RIPK3 inhibitor with an IC50 of 20 nM. |
|
V93289 | UNC0638 hydrate | 1255517-77-1 | UNC0638 hydrate selectively inhibits G9a and GLP histone methyltransferases with IC50 of 15 nM and 19 nM, respectively. |
|
V118688 | VF-57a | VF-57a (compound 23) is an influenza A virus (IAV) fusion inhibitor. | |
|
V119323 | VNT-101 | 2894060-67-2 | VNT-101 is an orally effective inhibitor of influenza A virus (IAV). |
|
V114448 | vRNPs degrader-1 | vRNP Degrader-1 is a highly efficient PROTAC viral ribonucleoprotein (vRNP) degrader. | |
|
V5118 | Oseltamivir phosphate (GS-4104) | 204255-11-8 | Oseltamivir phosphate (GS 4104;Tamiflu) is a potent neuraminidase inhibitor and an approved antiviral drug that has been widely used for the treatment and prophylaxis of influenza A and B. |
|
V10815 | Chebulinic Acid | 18942-26-2 | Chebulinic Acid is a naturally occurringellagitannin isolated from T. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
